Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18177970 | 0.75 | L3MBTL1 (0.39) | GAAATML3MBTL1TDP1KMT2A | |
| SCHEMBL4610161 | 0.73 | CES1 (0.39) | RECQLL3MBTL1TDP1KMT2AHSD17B10 | |
| SCHEMBL18177965 | 0.72 | ALDH1A1 (0.38) | ATML3MBTL1TDP1KMT2AHSD17B10 | |
| SCHEMBL16639436 | 0.69 | ALDH1A1 (0.46) | GAAATML3MBTL1TDP1KMT2A | |
| SCHEMBL14967665 | 0.69 | ALDH1A1 (0.46) | GAAATML3MBTL1TDP1KMT2A | |
| SCHEMBL4672996 | 0.65 | ELANE (0.52) | GAAATML3MBTL1TDP1HSD17B10 | |
| Acetic Acid Phenyl Ester SCHEMBL1309011 | 0.65 | ELANE (0.67) | GAATDP1KMT2AHSD17B10HPGD | |
| Methyl Alcohol SCHEMBL28471241 | 0.65 | TDP1 (0.47) | GAAATML3MBTL1TDP1KMT2A | |
| SCHEMBL3302 | 0.64 | TDP1 (0.50) | ATML3MBTL1TDP1HSD17B10HPGD | |
| Benzene SCHEMBL7925278 | 0.64 | TDP1 (0.50) | ATML3MBTL1TDP1HSD17B10HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10374256-B2 | Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same | UBE INDUSTRIES, LTD. (JP) | 2019-08-06 | — | — | US | disclosed |
| US-20160315351-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHONOFORMIC ACID COMPOUND USED IN SAME | UBE INDUSTRIES, LTD (JP) | 2016-10-27 | — | — | US | disclosed |
| US-20160315351-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHONOFORMIC ACID COMPOUND USED IN SAME | UBE INDUSTRIES, LTD (JP) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10374256-B2 | Nonaqueous electrolyte solution, electricity storage device using same, and phosphonoformic acid compound used in same | HCN2, PHOSPHO1, HCN1 | GAA 4607/4885RECQL 1365/4885ATM 1774/4885 |
| US-20160315351-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, ELECTRICITY STORAGE DEVICE USING SAME, AND PHOSPHONOFORMIC ACID COMPOUND USED IN SAME | HCN2, PHOSPHO1, HCN1 | GAA 4607/4885RECQL 1365/4885ATM 1774/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.